Improving patient access to hepatitis C virus treatment

McLaughlin Milena M.; Marx Kevin T.; Terriff Colleen

首页> 外文期刊>Journal of the American Pharmacists Association: JAPhA >Improving patient access to hepatitis C virus treatment

【24h】

Improving patient access to hepatitis C virus treatment

机译：改善患者获得丙型肝炎病毒治疗

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives: To discuss the current barriers to hepatitis C virus (HCV) treatment; to provide information and resources to assist health care providers with the prior authorization process; to provide resources for potential access to medications if a patient's third-party payer may not be an option; and to discuss the pharmacist's vital role as a patient advocate and considerations once medications are approved.

机译：目标：讨论丙型肝炎病毒（HCV）治疗的当前障碍; 提供信息和资源，以协助卫生保健提供者进行先前的授权流程; 如果患者的第三方付款人可能不是一个选择，则提供资源以潜在访问药物; 并讨论药剂师作为患者倡导者的重要作用，一旦批准药物，就会批准药物。

著录项

来源
《Journal of the American Pharmacists Association: JAPhA》 |2018年第1期|共5页
作者
McLaughlin Milena M.; Marx Kevin T.; Terriff Colleen;
展开▼
作者单位

Midwestern Univ Chicago Coll Pharm Pharm Practice Downers Grove IL 60515 USA;

Jeffrey Goodman Special Care Clin &

Pharm Los Angeles CA USA;

Deaconess Hosp Spokane WA USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Improving patient access to hepatitis C virus treatment [J] . McLaughlin Milena M., Marx Kevin T., Terriff Colleen Journal of the American Pharmacists Association: JAPhA . 2018,第1期

机译：改善患者获得丙型肝炎病毒治疗
2. Hepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected People Who Inject Drugs in Guangzhou, China: Implications for HCV Treatment Expansion [J] . Weiping Cai, Joseph D. Tucker, Paul Volberding, Open Forum Infectious Diseases . 2016,第2期

机译：在中国广州，人类免疫缺陷病毒和丙型肝炎病毒（HCV）合并感染人群中的丙型肝炎病毒治疗途径：扩大HCV治疗的意义
3. Treatment Coverage and Drug Expenditure in Hepatitis C Patients From 2013 to 2019: A Journey of Improving Treatment Accessibility in Malaysia Through Government-led Initiatives [J] . Chan Huan-Keat, Hassali Mohamed Azmi, Said Rosaida, Hepatitis Monthly . 2020,第9期

机译：2013年至2019年丙型肝炎患者的治疗覆盖率和药物支出：通过政府主导的举措提高马来西亚治疗可获得性的旅程
4. HLA-C gene in Hepatitis C Virus infected Patients in Egypt, to estimate the relation between HLA-C gene and Interferon/Ribavirin as treatment for hepatitis C virus [C] . SHADEN MUAWIA HANAFY, AMAL AHMED ABBAS, SAFY KABEEL ALY MANSOUR International Conference on Cellular and Molecular Biology, Biophysics and Bioengineering . 2015

机译：HLA-C基因在丙型肝炎病毒中感染埃及患者，估计HLA-C基因和干扰素/利巴韦林与丙型肝炎病毒治疗的关系
5. Impacts of Hepatitis C Virus Infection Treatment for Patients in Treatment for Opioid Use Disorder [D] . Severe, Brooke. 2019

机译：丙型肝炎病毒感染治疗对患者的影响对阿片类药物使用障碍的影响
6. Hepatitis C Virus Treatment Access Among Human Immunodeficiency Virus and Hepatitis C Virus (HCV)-Coinfected People Who Inject Drugs in Guangzhou China: Implications for HCV Treatment Expansion [O] . Carissa E. Chu, Feng Wu, Xi He, 2016

机译：在中国广州人类免疫缺陷病毒和丙型肝炎病毒（HCV）合并感染人群中的丙型肝炎病毒治疗途径：HCV治疗范围的扩大
7. High Treatment Uptake in Human Immunodeficiency Virus/Hepatitis C Virus–Coinfected Patients After Unrestricted Access to Direct-Acting Antivirals in the Netherlands [O] . Anne Boerekamps, Astrid M Newsum, Colette Smit, 2017

机译：在无限制地访问荷兰的直接代理抗病毒术后，人类免疫缺陷病毒/丙型肝炎病毒 - 乙型肝炎病毒的高治疗摄取

Improving patient access to hepatitis C virus treatment

摘要

著录项

相似文献

相关主题

期刊订阅